EZH2 and hepatocellular carcinoma: In addition, the combination of 14-3-3σ and EZH2 can predict the prognosis of HCC, which suggests that no regulatory relationship exists between 14-3-3σ and EZH2 expression, but the combination of the two genes could become candidate indicators for monitoring the prognosis of HCC.